#therapeutics — Friday, August 28, 2026 (3 items)
| 0 | ℹ |
Eplontersen for Transthyretin Amyloid Cardiomyopathy.
(nejm.org)
|
New England Journal of Medicine 2026-08-28 | #amyloid #cardiomyopathy #clinical trial #oligonucleotide #therapeutics | |
| 0 | ℹ |
Safety and lipoprotein(a)-lowering effects of Kylo-11, a non-canonical, long-duration small interfering RNA targeting lipoprotein(a): a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial.
(linkinghub.elsevier.com)
|
The Lancet 2026-08-28 | #clinical trial #rnai #therapeutics #cardiovascular #lipidomics | |
| 0 | ℹ |
Structure-function analysis of the FCRL5-IgG1 Fc complex reveals an unappreciated pathway for B cell modulation by Fc-attenuated IgG.
(science.org)
|
Science Advances 2026-08-28 | #antibody #immunology #crystallography #b-cells #therapeutics |